Drug discovery and life sciences product developer Caliper Life Sciences of Hopkinton, MA, has received an order from the U.S. National Cancer Institute (NCI) for its Quantum FX product.
The standalone microCT system for preclinical imaging will be used to study spontaneous tumor models in lung cancer. Data captured on the Quantum FX can be coregistered with other imaging modalities, the company said.
Related Reading
Caliper debuts Living Image module, September 13, 2010
Carestream sues Caliper over patents, July 13, 2010
Caliper adds microCT system, April 23, 2010
Caliper launches Living Image 4.0, December 3, 2009
Caliper adds to in vivo imaging line, September 10, 2009
Copyright © 2010 AuntMinnie.com
